Sharp Edge Labs logo — Advancing cellular biology research with innovative biosenso...

Sharp Edge Labs

Advancing cellular biology research with innovative biosensor technology for precise, high-throughput screening since 2011. Based in Pittsburgh, Pennsylvania.

Founded 2010 2-10 employees Series Unknown Total: $4.60M Biotechnology, Life Sciences +1

General Information

Company Name Sharp Edge Labs
Founded Year 2010
Founders / Decision Makers
Team member
Employees 2-10
Industries Biotechnology, Life Sciences, Medical Devices
Funding Stage Series Unknown
Social

Get notified when Sharp Edge Labs moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Sharp Edge Labs

Sharp Edge Labs is a biotechnology startup that has been advancing cellular biology research since 2011. Based in Pittsburgh, Pennsylvania, the company specializes in innovative biosensor technology for precise, high-throughput screening. Utilizing fluorogenic activating proteins, Sharp Edge Labs offers a range of specialized biosensors designed for the cellular biology research sector. These biosensors provide a method for detecting cellular changes suitable for high-throughput screening and subsequent analysis. Founded in 2011, Sharp Edge Labs has garnered attention within the industries of biotechnology, life sciences, and medical devices. Notably, the company received a $3.55M Venture Round investment on 08 August 2019. Despite the absence of disclosed investors, this investment underscores the market's confidence in the potential of Sharp Edge Labs and their innovative biosensor technology.

Taxonomy: Biosensors, Cellular Biology Research, High-throughput Screening, Fluorogenic Activating Proteins, Drug Discovery, Genetic Diseases, Life Sciences, Innovation, Research and Development, Pittsburgh, Pennsylvania, Start-up, Investment, Technology

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• - 08 Aug 2019
Series C •••••• 1
Investor
30 Jun 2017
Convertible Note •••••• 1
Investor
03 Sep 2016
Series B •••••• 2
Investor Investor
19 Aug 2014
Venture Round •••••• - 10 Jan 2014

View All 7 Funding Rounds

Sharp Edge Labs Alternatives & Competitors

Sharp Edge Labs vs
GNF
GNF United States

The Genomics Institute of the Novartis Research Foundation (GNF), founded in 1999 and now with over...

464 employees
Pharmaceutical
Sharp Edge Labs vs

Pioneering biomedicine with innovative enzyme research and comprehensive technical expertise across...

Series C
Manufacturing
Sharp Edge Labs vs

Viron is a biopharmaceutical company focused on breakthrough discovery and advanced technologies to...

Series B
Health Care

FAQ About Sharp Edge Labs

Advancing cellular biology research with innovative biosensor technology for precise, high-throughput screening since 2011. Based in Pittsburgh, Pennsylvania.
Sharp Edge Labs was founded in 2010.
Sharp Edge Labs operates in the following industries: Biotechnology, Life Sciences, Medical Devices.
Sharp Edge Labs has approximately 2-10 employees.
Sharp Edge Labs has completed 7 funding rounds, raising a total of $4.60M. The latest funding stage is Series Unknown.
Top alternatives and competitors to Sharp Edge Labs include GNF, Bohai New Enzyme, Viron, Helixon, Cerillo. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Sharp Edge Labs and GNF are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Sharp Edge Labs and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy